Osei K, Cottrell D A, Harris B
Department of Internal Medicine, Ohio State University, Columbus 43210-1296.
J Clin Endocrinol Metab. 1992 Jul;75(1):82-6. doi: 10.1210/jcem.75.1.1619033.
Black Americans (blacks) have a higher prevalence and earlier onset of type 2 diabetes than white Americans (whites). To examine metabolic differences in both races, we measured the basal glucose turnover rates (D-]3-3H]glucose technique) and plasma glucose, insulin, and C-peptide levels before and after an oral glucose load in 24 glucose-tolerant black and 14 white female relatives of patients with type 2 diabetes. Eight black and 8 white female subjects with no family history of diabetes served as controls. Mean fasting and postglucose plasma glucose levels were not significantly different between the black and white relatives and the control subgroups. Mean fasting plasma insulin and C-peptide levels were slightly greater but not significantly different between the relatives. After oral glucose ingestion, mean incremental integrated plasma insulin areas were significantly (P less than 0.02) greater in the black than the white relatives (70 +/- 14 vs. 29 +/- 6 nM.min). In addition, incremental integrated C-peptide areas were greater in the black than the white relatives (303 +/- 55 vs. 115 +/- 33; P less than 0.005). Similarly, we found significantly greater integrated incremental insulin (61 +/- 11 vs. 22 +/- 3 nM.min; P less than 0.02) and C-peptide (248 +/- 58 vs. 47 +/- 16; P less than 0.005) areas in the black than the white controls, respectively. The estimated basal and postglucose hepatic insulin extraction values, expressed as molar ratios of C-peptide and insulin, were not significantly different between the relatives. While basal hepatic insulin extraction was significantly (P less than 0.05) lower in the black controls, the postprandial insulin clearance was not different between the black and white controls. Mean basal hepatic glucose production was greater (P less than 0.02) in the black than the white relatives (2.49 +/- 0.13 vs. 2.02 +/- 0.12 mg/kg.min). Similarly, the black controls had greater hepatic glucose production than the white controls (2.36 +/- 0.15 vs. 1.81 +/- 0.08 mg/kg.min; P less than 0.001). We conclude that basal and poststimulation glucose homeostatic regulation appear to be different in black and white females, regardless of family history of type 2 diabetes.
非裔美国人(黑人)患2型糖尿病的患病率高于美国白人(白人),且发病更早。为了研究这两个种族的代谢差异,我们采用D-[3-3H]葡萄糖技术测量了24名糖耐量正常的2型糖尿病患者的黑人女性亲属和14名白人女性亲属口服葡萄糖负荷前后的基础葡萄糖周转率以及血浆葡萄糖、胰岛素和C肽水平。8名无糖尿病家族史的黑人女性和8名白人女性作为对照。黑人亲属和白人亲属与对照组亚组之间的空腹和餐后血浆葡萄糖平均水平无显著差异。亲属之间的空腹血浆胰岛素和C肽平均水平略高,但无显著差异。口服葡萄糖后,黑人亲属的平均增量整合血浆胰岛素面积显著(P<0.02)大于白人亲属(70±14 vs. 29±6 nM·min)。此外,黑人亲属的增量整合C肽面积大于白人亲属(303±55 vs. 115±33;P<0.005)。同样,我们发现黑人对照组的整合增量胰岛素(61±11 vs. 22±3 nM·min;P<0.02)和C肽(248±58 vs. 47±16;P<0.005)面积分别显著大于白人对照组。以C肽与胰岛素的摩尔比表示的基础和餐后肝脏胰岛素提取值在亲属之间无显著差异。虽然黑人对照组的基础肝脏胰岛素提取显著(P<0.05)较低,但黑人与白人对照组的餐后胰岛素清除率无差异。黑人亲属的平均基础肝脏葡萄糖生成量大于白人亲属(2.49±0.13 vs. 2.02±0.12 mg/kg·min;P<0.02)。同样,黑人对照组的肝脏葡萄糖生成量大于白人对照组(2.36±0.15 vs. 1.81±0.08 mg/kg·min;P<0.001)。我们得出结论,无论有无2型糖尿病家族史,黑人和白人女性的基础和刺激后葡萄糖稳态调节似乎都有所不同。